Start your Trading & Investing Journey with us
Join our channel for Daily Free Trades with Live analysis on Youtube, Trade Setup with Important Levels, and Important Stock Market Updates
Invicta Diagnostic IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details
Invicta Diagnostic Limited IPO : Key Performance Indicators, PE Ratio, EPS, ROE, ROCE & RoNW
The Company Key Performance Indicates the pre-issue EPS of ₹5.86 and post-issue EPS of ₹3.92 for FY25. The pre-issue P/E ratio is 14.51x,while the post-issue P/E ratio is 21.68x against the Industry P/E ratio is 53.3x The company's ROE for FY25 is 44.28% and RoNW is 36.25% The Annualised EPS is ₹6.50x and P/E is
13.08x. These metrics suggest that the IPO is Fully priced.
Key Performance Indicator
| KPI | Values |
|---|---|
| EPS Pre IPO (Rs.) | 5.86 |
| EPS Post IPO (Rs.) | 3.92 |
| Adjusted 12M EPS Post IPO (Rs.) | 6.50 |
| P/E Pre IPO | 14.51 |
| P/E Post IPO | 21.68 |
| Adjusted 12M P/E Post IPO | 13.08 |
| ROE | 44.28% |
| ROCE | 42.00% |
| P/BV | 5.26 |
| Debt/Equity | 0.26 |
| RoNW | 36.25% |
| EBITDA Margin | 30.57% |
| PAT Margin | 16.33% |
© 2022 CA Abhay Varn. All Rights Reserved Abhayvarn.com
